Regulation

BAT recognizes and supports the objectives of governments in reducing smoking rates and the associated health impacts, as well as the role of regulation in achieving that objective.

We have consistently been clear in our support for regulations that are founded on robust evidence, tailored to local circumstances, and effective in achieving their intended policy goals, while also preventing unintended consequences, such as the growth of illegal markets.

Along with the industry, governments and the public health community have a key role to play in maximising the potential smokeless products to contribute to harm reduction. To achieve this objective, smokeless products must be supported by effective regulatory and policy regimes and complemented by responsible practices by the industry.

We want to contribute to the debate, offering information, ideas and practical steps to help regulators address the key issues facing the industry.

That is why, on issues such as the regulation of smokeless products, we have transparently provided relevant information to governments and regulators to ensure appropriate frameworks that are evidence-based, protect consumers, provide adults with information, and deter underage use.

Experience shows that where risk-proportionate regulation encourages smokers to choose these smokeless alternatives instead of cigarettes, smoking rates can be more effectively reduced compared to relying on coercive policies which are either outdated or bluntly seek to prohibit products or behaviours.

The UK serves as a compelling example of how a science and evidence-based approach to policy making can have a positive effect on public health.  While having a stringent approach to combustible tobacco products regulation, the UK has chosen to adopt a progressive approach to the regulation of vapor products. This, after having evaluated the evidence of their reduced risk compared to cigarettes and their potential as a harm reduction tool for smokers.

The regulatory landscape is evolving, and we are confident that an increasing number of countries will embrace progressive policies designed to encourage smokers to transition to less harmful alternatives. With the growing body of evidence, we are optimistic about the broader adoption of these advanced regulations, anticipating a significant decrease in global smoking rates.

At the heart of this evolution is the establishment of a collaborative dialogue that bridges the gap between policy makers, regulators, public health authorities, and the industry. Such a dialogue is crucial for accelerating the momentum towards effective tobacco harm reduction strategies. By fostering mutual understanding, stakeholders can work together to implement measures that promote public health while respecting consumer choice and innovation.

We have long supported the Organisation for Economic Cooperation and Development’s (OECD) Principles for Transparency and Integrity in Lobbying. Our Principles for Engagement provide clear guidance for our external engagement with regulators, politicians and other third parties.

We are transparent about what we think, supporting some new proposals and sometimes disagreeing with others. In instances where we disagree with proposed regulations due to their potential negative unintended consequences, we adopt a constructive approach. We propose viable alternatives that can still meet the objectives of governments, and we are committed to continuing this practice.